Clinical investigation demonstrated that serum VEGF-C and VEGF-A levels are higher in obese subjects and VEGF-C rather than VEGF-A is closely related to dyslipidemia and atherosclerosis (Wada et al., 2011). The gene discussed is VEGFC; the disease is atherosclerosis.